BRUCATO, Federica
BRUCATO, Federica
Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”
Comparison of two polygenic risk score to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects: Polygenic hypocholesterolemias
2022-01-01 Cefalu A.B.; Spina R.; Noto D.; Rabacchi C.; Giammanco A.; Simone M.L.; Brucato F.; Scrimali C.; Gueli-Alletti M.G.; Barbagallo C.M.; Tarugi P.; Averna M
Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients
2022-03-16 Noto, Davide; Spina, Rossella; Giammanco, Antonina; Barbagallo, Carlo M; Ganci, Antonina; Scrimali, Chiara; Brucato, Federica; Misiano, Gabriella; Ciaccio, Marcello; Caldarella, Rosalia; Cefalù, Angelo Baldassare; Averna, Maurizio
GENETIC MARKERS OF DEVELOPMENT AND PROGRESSION OF THE ATHEROSCLEROSIS. POSSIBLE ROLE OF VARIANTS THAT CHANGE THE INTERACTIONS WITH THE PROTEOGLYCANS AND LIFETIME EXPOSURE TO LIPID RISK FACTORS IN CARDIOVASCULAR HIGH-RISK PATIENTS
2021-05-05
IDENTIFICATION OF P.LEU167DEL APOE GENE MUTATION BY NEXT GENERATION SEQUENCING IN A LARGE HYPERCHOLESTEROLEMIC FAMILY
2019-01-01 Scrimali, C; Spina, R; Ingrassia, V; Cefalu, AB; Brucato, F; Misiano, G; Valenti, V; Noto, D; Altieri, GI; Fayer, F; Giammanco, A; Barbagallo, C; Averna, M
MOLECULAR CHARACTERIZATION OF PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE WITH "EXTREME LDL-C PHENOTYPES"
2020-01-01 Brucato, F; Martinelli, N; Spina, R; Busti, F; Ingrassia, V; Scrimali, C; Altieri, GI; Noto, D; Misiano, G; Giammanco, A; Barbagallo, CM; Fayer, F; Cefalu, AB; Olivieri, O; Girelli, D; Averna, M
MUTATION IN CANDIDATE GENES ACCOUNT FOR A SMALL MINORITY OF HYPOBETALIPOPROTEINEMIAS AND NGS ANALYSIS SUPPORT POLYGENICITY IN MUTATION-NEGATIVE PATIENTS
2020-01-01 Giammanco, Antonina; Scrimali, C; Spina, R; Ingrassia, V; Brucato, F; Valenti, V; Cefalu, AB; Misiano, G; Altieri, GI; Noto, D; Barbagallo, CM; Ganci, A; Fayer, F; Averna, M
PCSK9-D374Y MEDIATED LDL-R DEGRADATION CAN BE FUNCTIONALLY INHIBITED BY EGF-A AND TRUNCATED EGF-A PEPTIDES. AN IN VITRO STUDY
2020-01-01 Scrimali, C; Spina, R; Ingrassia, V; Brucato, F; Altieri, GI; Noto, D; Valenti, V; Misiano, G; Giammanco, A; Fayer, F; Barbagallo, CM; Ganci, A; Cefalu, AB; Averna, M
PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study
2020-01-01 Valenti V; Noto D; Giammanco A; Fayer F; Spina R; Altieri GI; Ingrassia V; Scrimali C; Barbagallo CM; Brucato F; Misiano G; Cefalu AB; Averna M.
PREVALENCE OF STATIN INTOLERANCE IN A COHORT OF OUTPATIENTS IN A LIPID CLINIC
2019-01-01 Giammanco, A; Noto, D; Trevisin, M; Mattina, A; Cardella, A; Spina, R; Scrimali, C; Brucato, F; Ingrassia, V; Valenti, V; Misiano, G; Barbagallo, CM; Ganci, A; Cefalu, AB; Averna, M
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography
2021-01-01 Noto D.; Cefalu A.B.; Martinelli N.; Giammanco A.; Spina R.; Barbagallo C.M.; Caruso M.; Novo S.; Sarullo F.; Pernice V.; Brucato F.; Ingrassia V.; Fayer F.; Altieri G.I.; Scrimali C.; Misiano G.; Olivieri O.; Girelli D.; Averna M.